Nano Labs Announces Annual General Meeting
Nano Labs (Nasdaq: NA) has announced its 2024 Annual General Meeting of Shareholders, scheduled for October 23, 2024, at 10 A.M. Beijing time. The meeting will address three key points:
1. A share consolidation, merging every ten shares into one, changing the par value from US$0.0002 to US$0.002.
2. Amending the company's memorandum and articles of association to reflect this consolidation.
3. Appointing MaloneBailey, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
The record date for shareholder voting eligibility is set for September 27, 2024. If approved, the share consolidation will take effect on October 29, 2024, with trading on the Nasdaq Capital Market expected to begin on a post-consolidation basis the following business day.
Nano Labs (Nasdaq: NA) ha annunciato la sua Assemblea Annuale degli Azionisti del 2024, prevista per il 23 ottobre 2024, alle 10:00 ora di Pechino. L'incontro affronterà tre punti chiave:
1. Una consolidazione delle azioni, unendo ogni dieci azioni in una, cambiando il valore nominale da US$0,0002 a US$0,002.
2. Modifica del memorandum e dello statuto dell'azienda per riflettere questa consolidazione.
3. Nomina di MaloneBailey, LLP come società di contabilità pubblica indipendente registrata per l'anno fiscale che termina il 31 dicembre 2024.
La data di registrazione per l'idoneità al voto degli azionisti è fissata per il 27 settembre 2024. Se approvata, la consolidazione delle azioni entrerà in vigore il 29 ottobre 2024, con l'inizio delle negoziazioni sul Nasdaq Capital Market previsto per il giorno lavorativo successivo.
Nano Labs (Nasdaq: NA) ha anunciado su Junta General Anual de Accionistas para 2024, programada para el 23 de octubre de 2024, a las 10:00 hora de Pekín. La reunión abordará tres puntos clave:
1. Una consolidación de acciones, fusionando cada diez acciones en una, cambiando el valor nominal de US$0,0002 a US$0,002.
2. Modificación del memorando y los artículos de asociación de la empresa para reflejar esta consolidación.
3. Nombramiento de MaloneBailey, LLP como la firma de contabilidad pública independiente registrada para el año fiscal que finaliza el 31 de diciembre de 2024.
La fecha de registro para la elegibilidad de votación de los accionistas se establece para el 27 de septiembre de 2024. Si se aprueba, la consolidación de acciones entrará en vigor el 29 de octubre de 2024, con el comercio en el Nasdaq Capital Market previsto para comenzar el siguiente día hábil.
Nano Labs (Nasdaq: NA)는 2024년 주주 총회를 2024년 10월 23일 베이징 시간으로 오전 10시에 예정했다고 발표했습니다. 이번 회의에서는 세 가지 주요 사항을 다룰 예정입니다:
1. 주식 통합, 즉 매 10주의 주식을 1주로 합치고 액면가를 US$0.0002에서 US$0.002로 변경합니다.
2. 이 통합을 반영하기 위해 회사의 정관 및 기본약관을 수정합니다.
3. 2024년 12월 31일에 끝나는 회계연도에 대해 MaloneBailey, LLP를 독립 등록 공공 회계법인으로 임명합니다.
주주 투표 자격의 기준일은 2024년 9월 27일로 설정됩니다. 승인될 경우, 주식 통합은 2024년 10월 29일부터 시행되며, Nasdaq Capital Market에서의 거래는 다음 영업일에 통합 이후 기초로 시작될 것으로 예상됩니다.
Nano Labs (Nasdaq: NA) a annoncé sa Réunion Annuelle des Actionnaires pour 2024, prévue le 23 octobre 2024, à 10h00 heure de Pékin. La réunion abordera trois points clés :
1. Une consolidation des actions, fusionnant dix actions en une, modifiant la valeur nominale de 0,0002 US$ à 0,002 US$.
2. Modification du mémorandum et des statuts de l'entreprise pour refléter cette consolidation.
3. Nommer MaloneBailey, LLP en tant que cabinet d'expertise comptable public indépendant pour l'exercice financier se terminant le 31 décembre 2024.
La date d'enregistrement pour l'éligibilité au vote des actionnaires est fixée au 27 septembre 2024. Si elle est approuvée, la consolidation des actions entrera en vigueur le 29 octobre 2024, et les échanges sur le Nasdaq Capital Market devraient commencer sur une base post-consolidation le jour ouvrable suivant.
Nano Labs (Nasdaq: NA) hat seine Jahreshauptversammlung 2024 der Aktionäre für den 23. Oktober 2024, um 10:00 Uhr Pekinger Zeit, angekündigt. Die Versammlung wird drei zentrale Punkte behandeln:
1. Eine Aktienkonsolidierung, bei der jeweils zehn Aktien zu einer Aktie zusammengelegt werden, und der Nennwert von US$0,0002 auf US$0,002 geändert wird.
2. Änderung des Gesellschaftsvertrags und der Satzung des Unternehmens, um diese Konsolidierung widerzuspiegeln.
3. Bestellung von MaloneBailey, LLP als unabhängiges registriertes öffentliches Rechnungswesen für das zum 31. Dezember 2024 endende Geschäftsjahr.
Das Stichtagsdatum für die Wahlberechtigung der Aktionäre ist auf den 27. September 2024 festgelegt. Bei Genehmigung tritt die Aktienkonsolidierung am 29. Oktober 2024 in Kraft, wobei der Handel an der Nasdaq Capital Market am folgenden Geschäftstag nach der Konsolidierung beginnen soll.
- Share consolidation may improve stock liquidity and attract institutional investors
- Appointment of a new independent accounting firm suggests commitment to financial transparency
- Share consolidation could potentially reduce the total number of outstanding shares, affecting trading volume
HANGZHOU, China, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” “the Company,” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, today announced that it will hold its 2024 Annual General Meeting of Shareholders (the “2024 Annual Meeting”) at 10 A.M. on October 23, 2024, Beijing time (10 P.M. on October 22, 2024, U.S. Eastern time) in China Yuangu Hanggang Technology Building, 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People's Republic of China. The Company has established the close of business on September 27, 2024, Eastern time (the “Record Date”), as the record date for determining shareholders entitled to notice of, and to vote at, the Meeting and any adjournments or postponements thereof. The purpose of the Meeting is:
(1) to effect a share consolidation of every ten shares with a par value of US
(2) to amend the Company’s memorandum and articles of association currently in effect (the “Current M&A”) by the adoption of a new memorandum and articles of association to reflect the Share Consolidation (after the amendment, the “New M&A”); and
(3) to approve the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
Subject to obtaining the relevant shareholders' approval at the Meeting, the Share Consolidation will be effective at 5 P.M. on October 29, 2024, U.S. Eastern time, and the Class A ordinary shares are expected to begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market when markets open on the next business trading day under the new CUSIP/ISIN numbers. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Copies of the notice of the Meeting and the form of proxy are available on the Company’s corporate investor relations website at https://ir.nano.cn.
About Nano Labs Ltd
Nano Labs Ltd is a leading fabless integrated circuit (“IC”) design company and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips, high performance computing (“HPC”) chips, distributed computing and storage solutions, smart network interface cards (“NICs”) vision computing chips and distributed rendering. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab's Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company’s website at: ir.nano.cn.
*According to an industry report prepared by Frost & Sullivan.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s plan to appeal the Staff’s determination, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor inquiries, please contact:
Nano Labs Ltd
ir@nano.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
When is Nano Labs (NA) holding its 2024 Annual General Meeting?
What is the share consolidation ratio proposed by Nano Labs (NA)?
When will the Nano Labs (NA) share consolidation take effect if approved?